Consistent with previous studies, our study confirmed that weight gain may be the side effect of long-term insulin monotherapy in T1DM, which is the main reason that intensive insulin therapy fails to improve the microvascular and macrovascular complications of diabetes [1, 2, 46–48]. The gene discussed is INS; the disease is diabetes mellitus.